#USA #New York #Gross Law Firm #LifeMD #LFMD

Gross Law Firm Reminds Shareholders of LifeMD, Inc. Lawsuit

The Gross Law Firm has officially issued an important notice for shareholders of LifeMD, Inc. (NASDAQ: LFMD), warning them about an impending lead plaintiff deadline on October 25, 2025. This class action lawsuit invites those who purchased shares during the specified class period to take action and possibly become lead plaintiffs. Participation is crucial for those who feel they may have suffered losses due to the company's alleged misleading statements.

Class Period Details

The period in question runs from May 7, 2025, to August 5, 2025. Allegations against the defendants suggest that they issued materially false and misleading statements regarding LifeMD's market position and performance. Additionally, it is claimed that they failed to disclose critical information surrounding the costs associated with acquiring customers, particularly in relation to the RexMD segment and the sales of obesity treatment drugs like Wegovy and Zepbound.

These misleading statements reportedly inflated the company’s stock price, leading many investors to believe in a stability that did not exist. Shareholders are specifically being informed that filing as a lead plaintiff is not a prerequisite for recovery, encouraging broad participation in the lawsuit.

How to Register

Interested shareholders are encouraged to register their information via the Gross Law Firm’s platform. After registration, participants will gain access to portfolio monitoring software, providing ongoing updates regarding the lawsuit. The deadline to pursue the lead plaintiff role is set for October 25, 2025, emphasizing the importance of not delaying this process.

Why Choose Gross Law Firm?

The Gross Law Firm prides itself on being a nationally recognized class action firm, dedicated to safeguarding the rights of investors. Their mission centers around addressing issues of deceit, fraud, and unjust business practices. By holding companies accountable for their actions, particularly those that result in significant investor losses, the firm works towards restoring trust and ethical standards in corporate governance.

Conclusion

Investors who feel they have been wronged during the specified time frame are strongly urged to take the necessary steps to ensure their voices are heard. Registration can be completed through the firm’s designated link, where further guidance will be available on how to proceed. The upcoming lead plaintiff deadline is a critical date for shareholders of LifeMD, and engaging in this process could potentially lead to financial recovery for those affected.

For any inquiries or assistance, please contact The Gross Law Firm at their Manhattan location. Investors deserve to be informed and supported during these challenging times, and a proactive approach could make a significant difference in the outcomes of this case.